Vedana Therapeutics Advances Migraine Antibody Pipeline | Lucid Diligence Brief
Vedana Therapeutics has emerged from stealth with $46 million in Series A…
Servier Edgewise Sevasemten Deal | Lucid Diligence Brief
Servier’s Edgewise acquisition puts sevasemten’s Becker muscular dystrophy data…
Public Health Today—May 1, 2026
This is a weekly update in public health, highlighting advances across clinical…
Lucid Diligence Brief: Eli Lilly Pipeline Rationalization
Lucid Diligence Brief: Eli Lilly Pipeline Rationalization Professional…
Lucid Diligence Brief: Sanofi and ADEL sign global licensing deal in Alzheimer's
Lucid Diligence Brief: Sanofi and ADEL sign global licensing deal in…
Rare Diseases Weekly News - August 7th 2025
🧬 This Week in Rare Diseases: Europe’s R&D at Risk, AI Drug Discovery, New…
Trending at AAN 2025: Social Media Insights from X
📊 AAN 2025 Social Media Insights
📥 Download the Full Report!
Dive deeper
Women's Health Weekly News - June 11th 2025
Women’s Health Update: From Ground-Breaking Antidepressant Results to Policy…
Public Health Weekly News - May 16th 2025
Latest Public Health Updates: Weight Loss, Inverse Vaccines, Alzheimer’s &…
ASGCT 2025 Preview
🔬 ASGCT 2025: Transforming Medicine with Gene Editing, Cell Therapies &……
Neuroscience Weekly News - May 7th 2025
🧪 🧠MS Trial Expansion, Dual Migraine-Depression Therapy, Schizophrenia…
Neuroscience Weekly News - April 30th 2025
🧪 MS Trial Expansion, AI for MS Diagnosis, Alzheimer's Patent, Duchenne…